Head-to-head · Value Score
CoreAge Rx vs Clume Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Clume Health a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameClume Health
#253 · Grade C · Watch List
Est. first month
$259/mo month-to-month (full dose, oral or injectable; $186/mo only on a 52-week plan)
Save ~81% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. Clume Health isn't out of it: Shoppers who want the oral and injectable routes priced identically and will read the plan cards rather than the homepage before budgeting.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Clume Health |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | $259/mo month-to-month (full dose, oral or injectable; $186/mo only on a 52-week plan) |
| Save vs brand-name | ~89% | ~81% |
| Semaglutide | $99/mo | $259/mo month-to-month (full dose, oral or injectable; $186/mo only on a 52-week plan) |
| Tirzepatide | $149/mo | $259/mo month-to-month (the same figure as semaglutide; $186/mo only on a 52-week plan) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states and D.C. |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Clume Health
One price of $259 a month covers either molecule in either form, oral or injectable — advertised on the homepage as $199 a month, a figure that is not sold anywhere and whose asterisk resolves to no footnote.
Why it's a deal
- One figure covers a lot: $259 a month buys either molecule in either form, so switching from semaglutide to tirzepatide or from an injection to an oral dose does not move the bill
- The full price grid sits on the plan page before any intake, with the month-to-month rate printed beside each commitment rate rather than replacing it
- Four dispensing pharmacies are named, each with a website, a street address and a phone number — a level of supply-chain disclosure most desks at this price do not attempt
- Coverage is stated as all fifty states plus Washington, D.C., with the usual honest hedge that some services may be narrower, and the telehealth operator behind the care is named in the terms and the privacy policy
- Cancellation is by email or through the patient portal with seventy-two hours' notice, and the service continues through the period already paid for
The fine print
- The two prices on the homepage are not prices anyone pays. "$199/month" is advertised where the real floors are $259 and $219, and "$159/month" where the real figure is $216 — and that one is only available on a twelve-week plan
- Both homepage figures carry an asterisk that leads nowhere: the page holds three asterisks in total, the two price prefixes and one decoration, and no footnote exists on the page to explain either
- The cheaper per-month numbers are commitments printed as though they were rates: $186 a month requires a fifty-two-week plan, $200 a twelve-week one, and both sit on the same card as the month-to-month figure
- The longevity program publishes no month-to-month price at all — the only figure attached to it is a twelve-week rate
- Four pharmacies are named but the site never says which one fills which program, never states a 503A or 503B designation, and outside a definition in the terms never says the medication is compounded
- The refund policy promises a patient support line available around the clock while no phone number appears anywhere on the site; support is email only
- The company behind the brand publishes no address, and its legal entity appears only as a trading name in the terms
- The intake is now gated behind a security check before the first question, so the price cannot be confirmed at the point of purchase from outside
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Clume Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.